The role of tumor-associated macrophages in hepatocellular carcinoma progression: A narrative review

Cancer Med. 2023 Dec;12(24):22109-22129. doi: 10.1002/cam4.6717. Epub 2023 Dec 14.

Abstract

Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in the world, with complex etiology and mechanism, and a high mortality rate. Tumor-associated macrophages (TAMs) are an important part of the HCC tumor microenvironment. Studies in recent years have shown that TAMs are involved in multiple stages of HCC and are related to treatment and prognosis in HCC. The specific mechanisms between TAMs and HCC are gradually being revealed. This paper reviews recent advances in the mechanisms associated with TAMs in HCC, concentrating on an overview of effects of TAMs on drug resistance in HCC and the signaling pathways linked with HCC, providing clues for the treatment and prognosis determination of HCC.

Keywords: drug resistance; hepatocellular carcinoma; signaling pathway; tumor microenvironment; tumor-associated macrophages.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma, Hepatocellular* / pathology
  • Humans
  • Liver Neoplasms* / pathology
  • Macrophages / metabolism
  • Signal Transduction
  • Tumor Microenvironment
  • Tumor-Associated Macrophages / metabolism